CJC-1295 with DAC is a synthetic analog of growth hormone-releasing hormone (GHRH 1–29) engineered with specific amino acid modifications and a Drug Affinity Complex (DAC) attachment. The DAC moiety facilitates reversible binding to serum albumin, significantly extending the peptide’s plasma half-life up to 8–10 days and protecting it from proteolytic degradation. This design enables sustained, pulsatile GH release and subsequent elevation of IGF-1 levels, mimicking natural hormonal profiles.
Investigational studies utilize CJC-1295 with DAC to explore anabolic activity, lipolysis, and tissue repair, making it a potent tool for research centered on metabolic regulation and regenerative medicine.
For Research Use Only – Not for Human Consumption.